Potential Effects of the New Medicare Drug Benefit on Pricing for Psychotropic Medications

Ítems similars

• The New Medicare Drug Benefit: Formularies and Their Potential Effects on Access to Medications
  per: Huskamp, Haiden A, et al.
  Publicat: (2005)
• Prices, Profits and Innovation: Examining Criticisms of the Value of New Psychotropic Drugs
  per: Huskamp, Haiden A.
  Publicat: (2006)
• Pharmaceutical cost management and access to psychotropic drugs: The U.S. context
  per: Huskamp, Haiden A.
  Publicat: (2005)
• How The New Medicare Drug Benefit Could Affect Vulnerable Populations: Lower-income seniors and those with chronic illnesses could continue to have difficulty paying for their medications.
  per: Gellad, Walid F., et al.
  Publicat: (2006)
• Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019
  per: Dusetzina, Stacie B., et al.
  Publicat: (2019)